| Literature DB >> 26207928 |
Thomas Frenzel1, Rüdiger Lawaczeck, Matthias Taupitz, Gregor Jost, Jessica Lohrke, Martin A Sieber, Hubertus Pietsch.
Abstract
Over the last 120 years, the extensive advances in medical imaging allowed enhanced diagnosis and therapy of many diseases and thereby improved the quality of life of many patient generations. From the beginning, all technical solutions and imaging procedures were combined with dedicated pharmaceutical developments of contrast media, to further enhance the visualization of morphology and physiology. This symbiosis of imaging hardware and contrast media development was of high importance for the development of modern clinical radiology. Today, all available clinically approved contrast media fulfill the highest requirements for clinical safety and efficacy. All new concepts to increase the efficacy of contrast media have also to consider the high clinical safety standards and cost of goods of current marketed contrast media. Nevertheless, diagnostic imaging will contribute significantly to the progresses in medicine, and new contrast media developments are mandatory to address the medical needs of the future.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26207928 DOI: 10.1097/RLI.0000000000000193
Source DB: PubMed Journal: Invest Radiol ISSN: 0020-9996 Impact factor: 6.016